Skip to main content

Simpler.Grants.gov is the new way to search. To access classic search, you must sign in to www.grants.gov.

Search funding opportunities

Tip: Use a minus sign to exclude words or phrases, like "-research"

Must include all words (ex. transportation AND safety)

May include any words (ex. transportation OR safety)

Loading...

Loading the table...

Looking for U.S. government information and services? Visit USA.gov

653 Opportunities

Sort by

Close date	Status	Title	Agency	Award min	Award max
Close date Nov 10, 2026	Status Open	Title Data Coordinating Center for the Aging and Alzheimer’s Disease Mouse Brain Atlas (AD-MBA) (U24 Clinical Trial Not Allowed) Number: RFA-AG-27-010	Agency National Institutes of Health Posted date: Sep 1, 2026 Expected awards: 1	Award min $--	Award max $--
Close date Nov 10, 2026	Status Open	Title Infectious Diseases Clinical Trials Network (IDCTN) (UM1 Clinical Trial Required) Number: RFA-AI-27-002	Agency National Institutes of Health Posted date: Sep 1, 2026 Expected awards: --	Award min $--	Award max
Close date Nov 10, 2026	Status Open	Title Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required) Number: RFA-NS-26-001	Agency National Institutes of Health Posted date: May 4, 2026 Expected awards: 4	Award min $--	Award max
Close date Nov 10, 2026	Status Open	Title Clinical Research Network on Antimicrobial Resistance (UM1 Clinical Trial Required) Number: RFA-AI-27-005	Agency National Institutes of Health Posted date: Sep 1, 2026 Expected awards: 1	Award min $--	Award max
Close date Nov 10, 2026	Status Open	Title Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed) Number: RFA-CA-27-002	Agency National Institutes of Health Posted date: Jun 3, 2026 Expected awards: 13	Award min $--	Award max
Close date Nov 10, 2026	Status Open	Title Limited Competition: NIH Research Evaluation and Commercialization Hubs (REACH) (SB0 Clinical Trial Optional) Number: RFA-OD-27-009	Agency National Institutes of Health Posted date: Sep 24, 2026 Expected awards: 5	Award min $--	Award max
Close date Nov 10, 2026	Status Open	Title Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed) Number: RFA-CA-27-001	Agency National Institutes of Health Posted date: Jun 3, 2026 Expected awards: 20	Award min $--	Award max
Close date Nov 13, 2026	Status Open	Title NIDA Mentored Clinical Scientist Development Program Award in Substance Use and Substance Use Disorder Research (K12 Clinical Trial Optional) Number: PAR-24-089	Agency National Institutes of Health Posted date: Jan 3, 2024 Expected awards: --	Award min $--	Award max
Close date Nov 13, 2026	Status Open	Title NCCIH Natural Product Mid Phase Clinical Trial (R01 Clinical Trial Required) Number: PAR-25-271	Agency National Institutes of Health Posted date: Dec 2, 2024 Expected awards: --	Award min $--	Award max
Close date Nov 13, 2026	Status Open	Title NCCIH Natural Product Early Phase Clinical Trial Award (R33 Clinical Trial Required) Number: PAR-25-270	Agency National Institutes of Health Posted date: Dec 2, 2024 Expected awards: --	Award min $--	Award max
Close date Nov 13, 2026	Status Open	Title NCCIH Natural Product Early Phase Clinical Trial Phased Innovation Award (R61/R33 Clinical Trial Required) Number: PAR-25-269	Agency National Institutes of Health Posted date: Dec 2, 2024 Expected awards: --	Award min $--	Award max
Close date Nov 16, 2026	Status Open	Title Ethical, Legal and Social Implications (ELSI) Small Research Grant (R03 Clinical Trial Optional) Number: PAR-25-370	Agency National Institutes of Health Posted date: Jan 13, 2025 Expected awards: --	Award min $--	Award max
Close date Nov 17, 2026	Status Open	Title Prevention and Intervention Approaches for Fetal Alcohol Spectrum Disorders (R61/R33 Clinical Trial Optional) Number: PAR-25-158	Agency National Institutes of Health Posted date: Nov 25, 2024 Expected awards: --	Award min $--	Award max
Close date Nov 17, 2026	Status Open	Title Feasibility Clinical Trials of Mind and Body Interventions for NCCIH High Priority Research Topics (R34 Clinical Trial Required) Number: PAR-25-274	Agency National Institutes of Health Posted date: Nov 21, 2024 Expected awards: --	Award min $--	Award max
Close date Nov 17, 2026	Status Open	Title Single Source for the Continuation of the Physiology of the Weight Reduced State (POWERS) Study (U01- Clinical Trials Required) Number: RFA-DK-27-122	Agency National Institutes of Health Posted date: Oct 15, 2026 Expected awards: 1	Award min $--	Award max
Close date Nov 17, 2026	Status Open	Title Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R21 Clinical Trials Not Allowed) Number: PAR-25-096	Agency National Institutes of Health Posted date: Nov 18, 2024 Expected awards: --	Award min $--	Award max
Close date Nov 17, 2026	Status Open	Title NCCIH Multi-Site Feasibility Clinical Trials of Mind and Body Interventions (R01 Clinical Trial Required) Number: PAR-25-267	Agency National Institutes of Health Posted date: Nov 21, 2024 Expected awards: --	Award min $--	Award max
Close date Nov 17, 2026	Status Open	Title Investigator Initiated Clinical Trials of Complementary and Integrative Interventions Delivered Remotely or via mHealth (R01 Clinical Trial Required) Number: PAR-25-268	Agency National Institutes of Health Posted date: Nov 21, 2024 Expected awards: --	Award min $--	Award max
Close date Nov 18, 2026	Status Open	Title Ethical, Legal and Social Implications (ELSI) Research (R01 Clinical Trial Optional) Number: PAR-25-371	Agency National Institutes of Health Posted date: Jan 13, 2025 Expected awards: --	Award min $--	Award max
Close date Nov 18, 2026	Status Open	Title Ethical, Legal and Social Implications (ELSI) Exploratory/Developmental Research Grant (R21 Clinical Trial Optional) Number: PAR-25-369	Agency National Institutes of Health Posted date: Jan 13, 2025 Expected awards: --	Award min $--	Award max
Close date Nov 19, 2026	Status Open	Title Seamless Early-Stage Clinical Drug Development (Phase 1 to 2a) for Novel therapeutic Agents for the Spectrum of Alzheimer's Disease (AD) and AD-related Dementias (ADRD) (UG3/UH3 Clinical Trial Required) Number: PAR-25-226	Agency National Institutes of Health Posted date: Nov 22, 2024 Expected awards: --	Award min $--
Close date Nov 19, 2026	Status Open	Title NIH StrokeNet Clinical Trials and Biomarker Studies for Stroke Treatment, Recovery, and Prevention (UG3/UH3 Clinical Trial Optional) Number: PAR-25-052	Agency National Institutes of Health Posted date: Nov 20, 2024 Expected awards: --	Award min $--	Award max
Close date Nov 23, 2026	Status Open	Title HEAL Initiative: Pain Research Enhancement Program (PREP) (R15 Clinical Trial Optional) Number: RFA-AT-25-003	Agency National Institutes of Health Posted date: Jan 8, 2025 Expected awards: --	Award min $--	Award max
Close date Nov 23, 2026	Status Open	Title Cellular Senescence Network (SenNet): SenNet Technology Projects (SenTecs) (UG3/UH3 Clinical Trial Not Allowed) Number: RFA-RM-27-007	Agency National Institutes of Health Posted date: Oct 9, 2026 Expected awards: 15	Award min $--	Award max
Close date Nov 23, 2026	Status Open	Title Cellular Senescence Network (SenNet): SenNet Data Coordination and Integration Center (SenNet DCIC) (UM1 Clinical Trials Not Allowed) Number: RFA-RM-27-025	Agency National Institutes of Health Posted date: Oct 9, 2026 Expected awards: 1	Award min $--	Award max